Dublin, Nov. 28, 2019 (GLOBE NEWSWIRE) -- The "Pharmacovigilance and Drug Safety Software Market to 2027 - Global Analysis and Forecasts By Software Type; Delivery Mode; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The global pharmacovigilance (PV) and drug safety software market is expected to reach US$ 262.02 Mn in 2027 from US$ 151.07 Mn in 2018. The pharmacovigilance (PV) and drug safety software market is estimated to grow with a CAGR of 6.4% from 2019-2027.

The market is driven by factors such as, rising incidences of adverse drug reactions (ADRs) and globalization of pharmacovigilance. However, expensive technology may limit the growth of the market to a certain extent.

The pharmacovigilance (PV) and drug safety software are used to recognize the cause of drug withdrawal and helps to inhibit unnecessary future events. These software are beneficial to those involved in drug making process like clinical research organization and pharmaceutical companies. These software help companies to manage huge data generated due to adverse drug reaction events. Help to maintain data for regulatory inspection and approval. These software lets global information to be shared rapidly and economically.

Though there are many advantages of pharmacovigilance (PV) and drug safety software the software deployment cost is expensive. Large pharma companies having good infrastructure for pharmacovigilance process in house prefer for on-premise. These require huge capital upfront. Hence, high price for installation of pharmacovigilance (PV) and drug safety software is anticipated to hinder the growth of market.

Global pharmacovigilance (PV) and drug safety software market was segmented by software type, delivery mode and end user. The software type was segmented as fully integrated software, adverse event reporting software, drug safety audits software, and issue tracking software. By delivery mode it is categorized in on-premise and cloud based. By end-user contract research organizations (CRO's), pharmaceutical and biotech companies, business process outsourcing.

Some of the major primary and secondary sources included in the report are, Drug Safety and Effectiveness Network, European Medicines Agency, Food and Drug Administration, National Adverse Drug Event Monitoring Centre, National Center for Biotechnology Information, Pharmacovigilance Program of India, World Health Organization, Canadian Institutes of Health Research, Indian Council of Medical Research, Federation of Pharmaceutical Industries and Associations among others.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmacovigilance (PV) and drug safety market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global pharmacovigilance (PV) and drug safety market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market - By Software Type
1.3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market - By Delivery Mode
1.3.3 Global Pharmacovigilance (PV) and Drug Safety Software Market - By End-user
1.3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market - By Geography

2. Global Pharmacovigilance (PV) and Drug Safety Software Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Pharmacovigilance (PV) and Drug Safety Software Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions

5. Global Pharmacovigilance (PV) and Drug Safety Software Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences of Adverse Drug Reactions (ADRs)
5.1.2 Globalization of Pharmacovigilance
5.2 Key Market Restraints
5.2.1 Expensive Technology
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence in Pharmacovigilance
5.5 Impact Analysis

6. Pharmacovigilance (PV) and Drug Safety Software Market - Global Analysis
6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis
6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis - by Software Type
7.1 Overview
7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2018 & 2027 (%)
7.3 Adverse Event Reporting Software Market
7.4 Drug Safety Audits Software
7.5 Issue Tracking Software
7.6 Fully Integrated Software

8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis - by Delivery Mode
8.1 Overview
8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2018 & 2027 (%)
8.3 On-premise Market
8.4 Cloud- Based Market

9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis - by End-user
9.1 Overview
9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End-user 2018 & 2027 (%)
9.3 Pharmaceutical and Biotech Companies Market
9.4 Contract Research Organizations (CROs) Market
9.5 Business Process Outsourcing (BPO) Firms Market

10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.5 South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027

11. Pharmacovigilance (PV) and Drug Safety Software Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019
11.3 Organic Developments
11.4 Inorganic Developments

12. Pharmacovigilance (PV) and Drug Safety Software Market - Key Company Profiles
12.1 AB Cube
12.2 United Biosource LLC
12.3 ArisGlobal LLC
12.4 Sparta Systems
12.5 Oracle
12.6 Sarjen Systems Pvt. Ltd.
12.7 Extedo
12.8 Ennov
12.9 MaxApplication
12.10 Online Business Applications Inc.

For more information about this report visit https://www.researchandmarkets.com/r/75wvr0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900